US EditionANZSNM 55th annual conference in Melbourne – Australia - NeuroEndocrine Cancer Australia
Summary by NeuroEndocrine Cancer Australia
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
ANZSNM 55th annual conference in Melbourne – Australia - NeuroEndocrine Cancer Australia
Thank you to Simone Leyden AM, Director Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited ARCS Australia, for organising sponsorship for a group of nurses to attend ANZSNM Conference at the Melbourne Convention and Exhibition Centre (MCEC). With over 800 attendees, the conference was an incredibly informative gathering of leading scientists, physicists, nuclear […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
